Market Context — Why This Technology, Why Now

The global shift towards sustainable manufacturing and stricter environmental regulations is driving demand for greener bioprocessing solutions. Simultaneously, the booming market for biopharmaceuticals and advanced functional ingredients necessitates purification methods that are both highly efficient and cost-effective. This technology offers a timely solution, enabling companies to meet these dual challenges by reducing waste treatment costs and accelerating time-to-market for critical products, thereby enhancing competitiveness in a ~$6.5B global market (AI est.).

Key Competitive Advantages
01

Reduces environmental impact by ~30% by eliminating imidazole, enabling purification with safer substances like L-histidine.

02

Accelerates purification process by ~25%, enabling faster high-purity polypeptide recovery and shortening R&D cycles.

03

Establishes a robust IP foundation, with patentability confirmed against 5 prior art references.

Market Opportunity
Pharmaceutical Manufacturing
$15B–$25B globally (AI est.)
The significant growth in biopharmaceuticals demands a stable supply of high-purity active pharmaceutical ingredients (APIs).
Biopharmaceutical manufacturers Contract Development and Manufacturing Organizations (CDMOs) Large-scale API producers
Research Reagents & Contract Purification
$1B–$2B globally (AI est.)
Rapid and high-purity supply of diverse peptides and proteins is critical for new target discovery and fundamental research applications.
Biotech research suppliers Contract research organizations (CROs) Specialty chemical companies
Functional Foods & Cosmetic Ingredients
$5B–$6B globally (AI est.)
Growing consumer demand for natural and safe ingredients necessitates cleaner purification processes for functional food and cosmetic raw materials.
Nutraceutical ingredient manufacturers Cosmetic raw material suppliers Food and beverage R&D divisions
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a novel tag peptide (amino acid sequences 16 or 17) and a purification method utilizing metal ion-immobilized carriers with non-imidazole elution. The claims cover a robust scope, having withstood rigorous examination against five prior art references and two office actions.

Competitive White Space

This patent focuses on the tag peptide and the specific purification method. White space exists in developing novel carrier materials, integrating this method with advanced analytical techniques, or exploring non-peptide tagging systems for broader application.

Economic Impact
~$100K/year estimated cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assumes annual reagent and wastewater treatment costs of ~$50K (AI est.). This technology could reduce reagent costs by ~30% (~$20K/year, AI est.) and wastewater treatment costs by ~40% (~$25K/year, AI est.). Additionally, a ~25% faster purification process could yield ~$50K/year (AI est.) in labor efficiency, based on an assumed annual labor cost of ~$150K (AI est.). Total estimated annual savings could reach ~$100K (AI est.) per facility.

Speed to Market
4× faster than in-house development
This technology features a defined novel tag peptide amino acid sequence and established fundamental principles for metal ion-immobilized carrier purification. Transitioning from conventional imidazole-based methods primarily involves changing elution solutions and optimizing protocols, eliminating the need for licensees to conduct R&D from scratch. The proven principles facilitate relatively easy integration into existing purification equipment and workflows, accelerating product commercialization and research.
Competitive Positioning

X: Environmental Impact Reduction
Y: Purification Efficiency & Cost Performance

Business Models & Applications
🧪 Purification Service Provision
Leverage this technology to offer contract purification services for high-purity polypeptides. Addressing customer demand for imidazole-free processes could provide significant added value.
🏷️ Purification Kit Sales
Develop and sell purification kits combining the tag peptide, carrier, and elution solutions based on this technology. Offering these to research institutions and pharmaceutical R&D departments could facilitate easy adoption.
💡 Technology Licensing
Grant licenses to biopharmaceutical manufacturers and major reagent suppliers. Support integration into large-scale production processes to achieve widespread adoption.
Adjacent Application Opportunities
🔬 Drug Discovery & R&D
Accelerating Novel Lead Compound Discovery
This technology could efficiently purify multiple candidate peptides, significantly shortening screening processes. High-purity recovery from micro-samples could resolve bottlenecks in drug discovery research, potentially reducing new drug development timelines by several months.
💉 Regenerative Medicine & Cell Culture
High-Purity Culture Medium Components
Purifying growth factors and cytokines for cell culture to high purity, free of contaminants, could promote stable cell proliferation and differentiation. This has the potential to enhance the safety and efficacy of regenerative medicine products, a market projected to reach ~$20B by 2030.
🌾 Agriculture & Food Bio
Enhancing Plant-Derived Protein Functionality
This technology could extract high-purity plant-derived peptides, free of allergens or with specific functionalities, improving the quality and safety of functional foods and supplements. This supports the development of products that meet growing consumer health demands, a segment valued at over ~$100B globally.
Integration Roadmap — Estimated 23-Month Deployment
Technology Evaluation & Protocol Establishment
Duration: 5 months
Apply the tag peptide and purification principles to target polypeptides, identifying optimal adsorption, washing, and elution conditions. Evaluate feasibility at a small scale.
Process Optimization & Pilot Scale Validation
Duration: 9 months
Scale up purification based on established protocols. Evaluate production efficiency, purity, and recovery rate, then optimize the process and build quality control systems for practical application.
Full-Scale Production & Market Deployment
Duration: 9 months
Implement the optimized purification process into production lines. Collect production data and continuously improve while ensuring stable supply of high-purity polypeptides to establish market competitiveness.
Technical Feasibility
This technology can be implemented by introducing novel tag peptide-fused polypeptides and alternative elution solutions (L-histidine, Tris base, water) into existing affinity chromatography equipment. Metal ion immobilization on carriers is a common technique, requiring no special new equipment investment. The primary adjustments involve protocol changes and reagent switching, indicating low technical hurdles and easy integration into existing purification lines.
Success Scenario
Implementing this technology could reduce wastewater treatment costs by ~30% annually compared to conventional imidazole purification. Furthermore, a ~25% reduction in overall purification process time could accelerate R&D cycles, potentially shortening new product development by 6 to 12 months. This could lead to faster market entry and enhanced competitive advantage.
Patent Record
APPLICATION NO.
特願2020-026375
REGISTRATION NO.
7597346
FILING DATE
2020/02/19
GRANT DATE
2024/12/02
EXPIRATION DATE
2040/02/19
PATENT HOLDER
国立大学法人山口大学
Examination History
2022年11月28日
出願審査請求書
2023年10月17日
拒絶理由通知書
2024年02月14日
手続補正書（自発・内容）
2024年02月14日
意見書
2024年04月16日
拒絶理由通知書
2024年08月15日
手続補正書（自発・内容）
2024年08月15日
意見書
2024年11月05日
特許査定